.png){kind=small}
Episode 6: "The Gobblygook of Medicalization & Wonder of Plant" Medicine w/Simeon Schnapper"
Simeon is quoted (page 77) in this report from the Global Wellness Institute
Simeon appeared on Anne Philip's podcast to talk about his life as a venture capitalist.
Episode 65: "65: Simeon Schnapper on Researching & Investing in Psychedelic & Alternative Medicines"
Simeon Schnapper was the guest on this podcast – a free-wheeling discussion about his life and work.
Lindsay Hoover was interviewed for this article on MAPS PBC's milestone drug application filing with the FTC.
Simeon Schnapper was interviewed by Jen Coleman, CEO of Elevated Experiences, in advance of of his speaking appearance at Khaner Global's Cannabis and Psychedelics Investment conference later this month
Simeon Schnapper was interviewed for this article on the challenges facing the rapidly expanding psychedelics industry
Simeon Schnapper is among the major psychedelics VC & EFT directors who shared valuable insights at the Psychedelics Capital Conference (PCC)
How Awkn is navigating the tough market for investment capital
Psychedelics were the hot topic at the World Economic Forum 2022
How Awkn is navigating the tough market for investment capital
How Awkn is navigating the tough market for investment capital
He was the Canadian head of the world’s largest pot company. His next big bet? A rare fungus worth thousands a kilogram
Will Psychedelics Continue To Grow In 2021? Jeff Siegel Shares Insights And Strategies As More Companies Go Public
Investors are pouring millions into startups that are developing magic mushrooms as medications for conditions like depression and PTSD
Meet the top 14 psychedelics startups raising the most cash to develop new ways of treating depression, addiction, and more
